Pediatric anesthesia & critical care

Epinephrine dosing strategies during pediatric extracorporeal cardiopulmonary resuscitation reveal novel impacts on survival: A multicenter study utilizing time-stamped epinephrine dosing records

ResuscitationPublished Retrospective cohort study

Main finding · Adjusted survivalResult — go to the resultOdds ratio 0.78 95% CI 0.36–1.69

Authors' conclusion

Survivors received fewer doses than non-survivors after the first 10 minutes of CPR and although there was no statistical difference in survival based on dosing strategy, the findings of this study question the conventional approach to EPCR analysis that assumes dosing is evenly distributed.

Study context

Population
Children <18 years with an in-hospital ECPR event
Participants
191 children
Exposure
Frequent vs limited epinephrine dosing strategy during ECPR
Outcome
Survival
Methodological detailsmulticentre, 5 pediatric hospitals, time-stamped epinephrine dosing records
  • Multicentre
  • 5 pediatric hospitals
  • Time-stamped epinephrine dosing records

Main finding

Adjusted survival

Odds ratio

0.78

95% CI 0.36–1.69

P = 0.53

Frequent epinephrine vs Limited epinephrine
OR 0.78 (95% CI 0.36–1.69); P = 0.53

As reported in the abstract

Observational data: associations, not effects.

Further findings

Epinephrine dose distribution during ECPR

Doses given during the first half of the event
66%

Mean number of epinephrine doses, survivors vs non-survivors

Similar in first 10 minutes
2.7 doses
After 10 minutes, survivors received fewer doses than non-survivors in each subsequent 10-minute interval

Original publication

Epinephrine dosing strategies during pediatric extracorporeal cardiopulmonary resuscitation reveal novel impacts on survival: A multicenter study utilizing time-stamped epinephrine dosing records. Resuscitation. Published 29 May 2023. doi:10.1016/j.resuscitation.2023.109855

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.